Alex Craddock, the CMO at Citigroup, talks about innovative marketing content and thought leadership in financial services.

Citi initiated coverage on small- and mid-cap biotechnology companies on early signs of improving sentiment in a sector weighed down this year by policy uncertainty and weak investor interest.

Federal reviewers internally raised red flags about a Biden-era Environmental Protection Agency (EPA) program that awarded billions with minimal oversight ...

These five solid companies should continue to deliver big monthly dividends to shareholders, so they make sense now.

The CoinDesk Policy & Regulation conference (formerly known as State of Crypto) is a one-day boutique event held in ...

The Young Rich Listers fought tooth and nail to prevent being summoned and appearing in the witness box in an Australian ...

Pharma tariffs are going to come in at levels you haven’t really seen before. We are looking at pharmaceuticals as a separate ...

The billionaire attempted to settle a long-running dispute with his future sister-in-law six months after she launched her ...

Gold’s been on a tear but a new Wall Street forecast says the record run is poised to stop. Gold is trading close to all-time ...

Citi lowered its short-term and long-term price targets for gold, projecting prices could drop below $3,000 per ounce by late ...

JPMorgan Chase has filed a trademark application for “JPMD,” for it may be reportedly launching USD-backed stablecoin, J.P. Morgan Dollar.

Analysts at Citi said Vertiv is well-positioned to grow with the data center industry, reported Investing.com. Citi estimates ...